In an American Academy of Pediatrics policy statement, published online in Pediatrics, updated recommendations are presented relating to use of barrier methods for adolescents engaging in sexual activity.
The FDA has approved an expanded indication for Gardasil 9® (human papillomavirus 9-valent vaccine [HPV], recombinant; Merck) to include the prevention of oropharyngeal and other head and neck cancers caused by HPV Types 16, 18, 31, 33, 45, 52, and 58 in patients aged 9 to 45 years.
The purpose of the study was to identify barriers that prevent pediatric nurse practitioners from discussing high-risk sexual behaviors among adolescents during primary care visits.
Rates of chlamydia, gonorrhea, and syphilis increased 2, 16, and 34%, respectively.
A patient presents with a worsening rash on both of her legs that has persisted for 10 days.
Behavioral counseling linked to reduction in odds of STI and with reduction in sexual risk behaviors.
Age, racial/ethnic, and risk category disparities exist among patients who discontinue preexposure prophylaxis treatment after initiation.
Increasing availability of treatments will help public health officials stop increases in STIs, authors say.
A woman presents with gradually worsening, generalized abdominal pain that originated in the right lower quadrant.
Investigators of this study sought to compare the efficacy of a community health nursing intervention vs standard of care to improve self-management of pelvic inflammatory disease.
